Valuation Actuate Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 23:00:00 19/10/2026 +03			5-day change	1st Jan Change
0.5990 ^USD	-0.99%		-6.94%	-90.21%

10-07	Top Premarket Decliners	MT
09-09	Actuate Therapeutics Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with Ras Inhibitors Zoldonrasib and Daraxonrasib	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	155.5	142.2	14.38	-	-
Change	-	-8.5%	-89.89%	-	-
Enterprise Value (EV)	155.5	142.2	14.38	14.38	14.38
Change	-	-8.5%	-89.89%	0%	0%
P/E	-	-	-	-	-
PBR	-	-	-	-	-
PEG	-	-	-	-	-
Capitalization / Revenue	-	-	-	-	-
EV / Revenue	-	-	-	-	-
EV / EBITDA	-	-	-	-	-
EV / EBIT	-0x	-0x	-0.66x	-0.54x	-0.46x
EV / FCF	-	-0x	-0.68x	-0.54x	-0.46x
FCF Yield	-	-15.6%	-148%	-186%	-216%
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-	-	-	-	-
Distribution rate	-	-	-	-	-
Net sales ¹	-	-	-	-	-
EBITDA	-	-	-	-	-
EBIT ¹	-25.16	-22.5	-21.82	-26.61	-31.56
Net income	-	-	-	-	-
Net Debt	-	-	-	-	-
Reference price ²	7.9600	6.1200	0.5990	0.5990	0.5990
Nbr of stocks (in thousands)	19,532	23,243	24,014	-	-
Announcement Date	3/13/25 A	3/26/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ACTUATE THERAPEUTICS, INC.	-	-	-	-	14.53M
WUXI APPTEC CO., LTD.	18.77x	6.69x	13.41x	1.58%	65B
LONZA GROUP AG	35.3x	6.27x	18.74x	0.92%	51.2B
ARGENX SE	27.56x	7.53x	23.83x	0.05%	51.19B
IQVIA HOLDINGS INC.	34.01x	3.32x	14.33x	-.--%	43.93B
BEONE MEDICINES AG	48.9x	5.59x	30.73x	-.--%	41.96B
REVOLUTION MEDICINES, INC.	-18.47x	189.62x	-19.51x	-.--%	38.14B
CELLTRION, INC.	28.97x	8.21x	21.25x	0.37%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	29.19x	6.17x	16.01x	-.--%	25.2B
GENMAB A/S	30.74x	5.69x	19.09x	-.--%	22.5B
Average	26.11x	26.57x	15.32x	0.32%	37.24B
Weighted average by Cap.	25.97x	25.01x	15.48x	0.44%